lamivudine has been researched along with Critical Illness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chizzolini, C; Deléaval, P; Descombes, E; Hecker, E; Nicole, A; Pugin, P; Regamey, C; Schrago, G; Stadler, P | 1 |
1 other study(ies) available for lamivudine and Critical Illness
Article | Year |
---|---|
Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids.
Topics: Adult; Combined Modality Therapy; Critical Illness; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Plasma Exchange; Polyarteritis Nodosa; Recombinant Proteins; Risk Assessment; Steroids; Treatment Outcome | 2001 |